GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹122 Cr | ₹19 Cr | ₹23 Cr | ₹17 Cr | ₹14 Cr |
What is the latest Net Current Assets ratio of GENNEX LABORATORIES ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹122 Cr |
Mar2023 | ₹19 Cr |
Mar2022 | ₹23 Cr |
Mar2021 | ₹17 Cr |
Mar2020 | ₹14 Cr |
How is Net Current Assets of GENNEX LABORATORIES Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹122 Cr | 533.85 | |
Mar2023 | ₹19 Cr | -16.56 | |
Mar2022 | ₹23 Cr | 32.37 | |
Mar2021 | ₹17 Cr | 23.00 | |
Mar2020 | ₹14 Cr | - |
Compare Net Current Assets of peers of GENNEX LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GENNEX LABORATORIES | ₹329.0 Cr | 7.3% | -22.7% | -28.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,132.0 Cr | 2.2% | -5.8% | 22.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,254.0 Cr | 4.1% | -7% | 52% | Stock Analytics | |
CIPLA | ₹116,123.0 Cr | 1.3% | -4.8% | 9.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,573.0 Cr | 2.2% | -10.9% | -0.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,966.9 Cr | 7% | -0.2% | 27.5% | Stock Analytics |
GENNEX LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GENNEX LABORATORIES | 7.3% |
-22.7% |
-28.4% |
SENSEX | 2.8% |
-3.1% |
9% |
You may also like the below Video Courses